WANG Rui, JIN Ming-shun, Wang Wei, et al. Effect of Beta-asarone on Adriamycin-induced Cardiomyocyte Injury in Suckling Mouse[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(16): 202-205.
DOI:
WANG Rui, JIN Ming-shun, Wang Wei, et al. Effect of Beta-asarone on Adriamycin-induced Cardiomyocyte Injury in Suckling Mouse[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(16): 202-205. DOI: 10.11653/syfj2013160202.
Effect of Beta-asarone on Adriamycin-induced Cardiomyocyte Injury in Suckling Mouse
Objective: To observe the effect of beta-asarone on adriamycin-induced cardiomyocyte injury in suckling mouse. Method: Cardiomyocytes of neonate rat were cultivated for 72 hours and randomly divided into normal control group
adriamycin(ADR
2 mg·L-1) model group
and beta-asarone(10
20
40 mg·L-1) dose groups. MTT colorimetric method was deployed to detect cardiocyte survival rate
activities of medium lactate dehydrogenase(LDH)
superoxide dismutase(SOD) and malondialdehyde(MDA) were detected
and protein expression of B cell lymphoma/lewkmia-2(Bcl-2) and Bcl-2 associated X protein(Bax) were detected by immune histochemical method. Result: Compared with normal control group
model group ADR cardiomyocyte shrinkage deformation
irregular
beat rhythm irregularities
frequency obviously slow down
numbers of survival cells were decreased
the leakage of LDH was increased; SOD activity was decreased; the contents of MDA were increased; protein expressions of Bcl-2 were reduce
protein expressions of Bax were increased (P <0.01 or P <0.05). And compared with ADR model groupand ADR model group
each dose group of beta-asarone had no changes in cardiomyocytes cell pulsation frequency
present centrality synchronization pulsing; cardiomyocytes survival rate was increased; the leakages of LDH was decreased;and the activity of SOD was increased; contents of LDH and MDA were decreased; protein expression of Bcl-2 was increased
protein expression of Bax were reduced (P<0.01 or P <0.05). Conclusion: Beta-asarone protects mice from adriamycin-induced cardio-toxicity by reduction of oxygen free radicals and apoptosis in mouse cardiac tissues.